SEC
filing details

Document Details

Form
Filing Date
Feb 2, 2021
Document Date
Jan 30, 2021
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Ultragenyx Pharmaceutical Inc.
Issuer
Ultragenyx Pharmaceutical Inc.
Filer
Bedrosian Camille L
Sign up for Email Alerts
Email Alerts Sign-up